- Home
- VAL vs VKTX Comparison
VAL vs VKTX Comparison
Compare VAL & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VAL
- VKTX
- Stock Information
- Founded
- VAL 1975
- VKTX 2012
- Country
- VAL Bermuda
- VKTX United States
- Employees
- VAL 5642
- VKTX N/A
- Industry
- VAL Oil & Gas Production
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- VAL Energy
- VKTX Health Care
- Exchange
- VAL Nasdaq
- VKTX Nasdaq
- Market Cap
- VAL 3.3B
- VKTX 3.5B
- IPO Year
- VAL N/A
- VKTX 2015
- Fundamental
- Price
- VAL $45.20
- VKTX $40.03
- Analyst Decision
- VAL Hold
- VKTX Strong Buy
- Analyst Count
- VAL 7
- VKTX 13
- Target Price
- VAL $46.33
- VKTX $86.92
- AVG Volume (30 Days)
- VAL 1.3M
- VKTX 4.6M
- Earning Date
- VAL 07-30-2025
- VKTX 07-23-2025
- Dividend Yield
- VAL N/A
- VKTX N/A
- EPS Growth
- VAL N/A
- VKTX N/A
- EPS
- VAL 3.83
- VKTX N/A
- Revenue
- VAL $2,463,400,000.00
- VKTX N/A
- Revenue This Year
- VAL N/A
- VKTX N/A
- Revenue Next Year
- VAL $0.63
- VKTX $338.60
- P/E Ratio
- VAL $11.79
- VKTX N/A
- Revenue Growth
- VAL 18.77
- VKTX N/A
- 52 Week Low
- VAL $27.15
- VKTX $18.92
- 52 Week High
- VAL $65.68
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- VAL 43.11
- VKTX 69.97
- Support Level
- VAL $45.92
- VKTX $39.35
- Resistance Level
- VAL $48.20
- VKTX $41.68
- Average True Range (ATR)
- VAL 1.91
- VKTX 2.06
- MACD
- VAL -0.44
- VKTX 0.56
- Stochastic Oscillator
- VAL 13.81
- VKTX 84.10
About VAL Valaris Limited
Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.